Post Profile






Roche says gets breakthrough status for Actemra treatment for giant cell arteritis

ZURICH (Reuters) - Roche said the U.S. Food and Drug Administration has granted it breakthrough status to its anti-rheumatoid arthritis medication Actemra/RoActemra (tocilizumab) for giant cell arteritis (GCA).
read more

share

Related Posts


Biologic Treatment Could Change Current Standard Of Care For 160,000 People Living With Rheumatoid Arthritis

Health : Medical News Today

New data presented today at the European League Against Rheumatism congress demonstrated that RoActemra (tocilizumab) alone had comparable clinical efficacy to RoActemra plus methotrexate (MTX) in people with rheumatoid arthritis (R...

Breakthrough Treatment For Rheumatoid Arthritis Offers New Hope To Patients

Health : Medical News Today

Today's Irish launch of RoActemra, a new treatment for rheumatoid arthritis (RA) from Roche, is being hailed as a breakthrough in the fight against this incurable and often debilitating disease.

Roche's RoActemra® (Tocilizumab) Shows Long-Term Efficacy In Monotherapy And Also Benefits In Early Rheumatoid Arthritis

Health : Medical News Today

Roche (SIX: RO, ROG; OTCQX: RHHBY) have announced data from two phase III studies using RoActemra in patients with rheumatoid arthritis (RA): the long-term extension (LTE) follow up of the AMBITION study demonstrated long-term effic...

FDA Approves ACTEMRA(R) (Tocilizumab) For The Treatment Of Systemic Juvenile Idiopathic Arthritis (SJIA)

Health : Medical News Today

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA (tocilizumab) for the treatment of active Systemic Juvenile Idiopathic Arthritis ...

RoActemra Could Change The Current Standard Of Treatment For People Living With Rheumatoid Arthritis

Health : Medical News Today

Roche announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress. The results demonstrated that in people with rheumatoid arthritis (RA), RoACTEMRA (tocilizumab, known as ACTEMRA outside ...

Comments


Copyright © 2016 Regator, LLC